EP3260124
METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS
:
EP einkaleyfi: Þýðing ekki lögð inn:
14.5.2012:
12.7.2023:
17181203.5
:
13.5.2032
:
METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS
14.5.2012
12.7.2023
:
CSL Behring GmbH:
Emil-von-Behring-Strasse 76, 35041 Marburg, DE
:
Schulte, Stefan:
35043 Marburg, DE
:
Kalina, Uwe:
35041 Marburg, DE
:
Moses, Michael:
61279 Graevenwiesbach, DE
:
Feussner, Annette:
35043 Marburg, DE
:
11165869:
12.5.2011:
EP
:
201161487205 P:
17.5.2011:
US
:
A61K 38/38, A61K 31/727, A61K 35/16, A61K 38/57, A61P 1/00, A61P 7/02, A61P 9/06, A61P 9/12, A61P 11/08